Altered murine tissue colonization by Borrelia burgdorferi following targeted deletion of linear plasmid 17-carried genes

Infection and Immunity

Volumn 80, Issue 5, 2012, Pages 1773-1782

  Casselli, Timothy ^a   Tourand, Yvonne ^a   Bankhead, Troy ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; OUTER SURFACE PROTEIN C; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BBD16 GENE; BBD25 GENE; BORRELIA BURGDORFERI; CONTROLLED STUDY; CYSTITIS; GENE DELETION; IN VITRO STUDY; IN VIVO STUDY; LINEAR PLASMID 17; LYME DISEASE; MALE; MOUSE; NONHUMAN; OPEN READING FRAME; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BACTERIAL PROTEINS; BORRELIA BURGDORFERI; EAR; GENE DELETION; GENE EXPRESSION REGULATION, BACTERIAL; GENETIC COMPLEMENTATION TEST; HEART; IMMUNOCOMPROMISED HOST; JOINTS; LYME DISEASE; MICE; MICE, INBRED C3H; MICE, SCID; PLASMIDS; URINARY BLADDER;

EID: 84861153516     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05984-11     Document Type: Article

References (63)

1. Angel TE, et al. 2010. Proteome analysis of Borrelia burgdorferi response to environmental change. PLoS One 5:e13800.
2. Antonara S, Chafel RM, LaFrance M, Coburn J. 2007. Borrelia burgdorferi adhesins identified using in vivo phage display. Mol. Microbiol. 66:262-276.
3. Bankhead T, Chaconas G. 2007. The role of VlsE antigenic variation in the Lyme disease spirochete: persistence through a mechanism that differs from other pathogens. Mol. Microbiol. 65:1547-1558.
4. Barbour AG. 1984. Isolation and cultivation of Lyme disease spirochetes. Yale J. Biol. Med. 57:521-525.
5. Beaurepaire C, Chaconas G. 2005. Mapping of essential replication functions of the linear plasmid lp17 of B. burgdorferi by targeted deletion walking. Mol. Microbiol. 57:132-142.
6. Behera AK, et al. 2008. Borrelia burgdorferi BBB07 interaction with integrin alpha3beta1 stimulates production of pro-inflammatory mediators in primary human chondrocytes. Cell. Microbiol. 10:320-331.
7. Boardman BK, et al. 2008. Essential role of the response regulator Rrp2 in the infectious cycle of Borrelia burgdorferi. Infect. Immun. 76:3844-3853.
8. Bono JL, et al. 2000. Efficient targeted mutagenesis in Borrelia burgdorferi. J. Bacteriol. 182:2445-2452.
9. Brooks CS, Hefty PS, Jolliff SE, Akins DR. 2003. Global analysis of Borrelia burgdorferi genes regulated by mammalian host-specific signals. Infect. Immun. 71:3371-3383.
10. Burgdorfer W, et al. 1982. Lyme disease-a tick-borne spirochetosis? Science 216:1317-1319.
11. Caimano MJ, et al. 2007. Analysis of the RpoS regulon in Borrelia burgdorferi in response to mammalian host signals provides insight into RpoS function during the enzootic cycle. Mol. Microbiol. 65:1193-1217.
12. Casjens S, et al. 2000. A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Mol. Microbiol. 35:490-516.
13. Chaconas G, Stewart PE, Tilly K, Bono JL, Rosa P. 2001. Telomere resolution in the Lyme disease spirochete. EMBO J. 20:3229-3237.
14. Coburn J, Chege W, Magoun L, Bodary SC, Leong JM. 1999. Characterization of a candidate Borrelia burgdorferi beta3-chain integrin ligand identified using a phage display library. Mol. Microbiol. 34:926-940.
15. Coburn J, Magoun L, Bodary S, Leong JM. 1998. Integrins avb3 and a5b1 mediate attachment of Lyme disease spirochetes to human cells. Infect. Immun. 66:1946-1952.
16. Czub S, Duray PH, Thomas RE, Schwan TG. 1992. Cystitis induced by infection with the Lyme disease spirochete, Borrelia burgdorferi, in mice. Am. J. Pathol. 141:1173-1179.
17. Deneke J, Chaconas G. 2008. Purification and properties of the plasmid maintenance proteins from the Borrelia burgdorferi linear plasmid lp17. J. Bacteriol. 190:3992-4000.
18. Dulebohn DP, Bestor A, Rego RO, Stewart PE, Rosa PA. 2011. Borrelia burgdorferi linear plasmid 38 is dispensable for completion of the mousetick infectious cycle. Infect. Immun. 79:3510-3517.
19. Elias AF, et al. 2003. New antibiotic resistance cassettes suitable for genetic studies in Borrelia burgdorferi. J. Mol. Microbiol. Biotechnol. 6:29-40.
20. Fischer JR, LeBlanc KT, Leong JM. 2006. Fibronectin binding protein BBK32 of the Lyme disease spirochete promotes bacterial attachment to glycosaminoglycans. Infect. Immun. 74:435-441.
21. Fraser CM, et al. 1997. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390:580-586.
22. Goodman JL, Jurkovich P, Kodner C, Johnson RC. 1991. Persistent cardiac and urinary tract infections with Borrelia burgdorferi in experimentally infected Syrian hamsters. J. Clin. Microbiol. 29:894-896.
23. Grimm D, et al. 2004. Experimental assessment of the roles of linear plasmids lp25 and lp28-1 of Borrelia burgdorferi throughout the infectious cycle. Infect. Immun. 72:5938-5946.
24. Grimm D, Elias AF, Tilly K, Rosa PA. 2003. Plasmid stability during in vitro propagation of Borrelia burgdorferi assessed at a clonal level. Infect. Immun. 71:3138-3145.
25. Guo BP, Brown EL, Dorward DW, Rosenberg LC, Hook M. 1998. Decorin-binding adhesins from Borrelia burgdorferi. Mol. Microbiol. 30: 711-723.
26. Hagman KE, et al. 1998. Decorin-binding protein of Borrelia burgdorferi is encoded within a two-gene operon and is protective in the murine model of Lyme borreliosis. Infect. Immun. 66:2674-2683.
27. Hu LT, et al. 1997. Isolation, cloning, and expression of a 70-kilodalton plasminogen binding protein of Borrelia burgdorferi. Infect. Immun. 65: 4989-4995.
28. Jewett MW, et al. 2007. The critical role of the linear plasmid lp36 in the infectious cycle of Borrelia burgdorferi. Mol. Microbiol. 64:1358-1374.
29. Kawabata H, Norris SJ, Watanabe H. 2004. BBE02 disruption mutants of Borrelia burgdorferi B31 have a highly transformable, infectious phenotype. Infect. Immun. 72:7147-7154.
30. Kobryn K, Chaconas G. 2002. ResT, a telomere resolvase encoded by the Lyme disease spirochete. Mol. Cell 9:195-201.
31. Labandeira-Rey M, Seshu J, Skare JT. 2003. The absence of linear plasmid 25 or 28-1 of Borrelia burgdorferi dramatically alters the kinetics of experimental infection via distinct mechanisms. Infect. Immun. 71:4608-4613.
32. Labandeira-Rey M, Skare JT. 2001. Decreased infectivity in Borrelia burgdorferi strain B31 is associated with loss of linear plasmid 25 or 28-1. Infect. Immun. 69:446-455.
33. Lane RS, Piesman J, Burgdorfer W. 1991. Lyme borreliosis: relation of its causative agent to its vectors and hosts in North America and Europe. Annu. Rev. Entomol. 36:587-609.
34. Liang FT, Brown EL, Wang T, Iozzo RV, Fikrig E. 2004. Protective niche for Borrelia burgdorferi to evade humoral immunity. Am. J. Pathol. 165: 977-985.
35. Liang FT, Jacobs MB, Bowers LC, Philipp MT. 2002. An immune evasion mechanism for spirochetal persistence in Lyme borreliosis. J. Exp. Med. 195:415-422.
36. Liang FT, Nelson FK, Fikrig E. 2002. Molecular adaptation of Borrelia burgdorferi in the murine host. J. Exp. Med. 196:275-280.
37. Liang FT, et al. 2004. Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses. Infect. Immun. 72: 5759-5767.
38. Livengood JA, Schmit VL, Gilmore RD, Jr. 2008. Global transcriptome analysis of Borrelia burgdorferi during association with human neuroglial cells. Infect. Immun. 76:298-307.
39. Miller JC, et al. 2000. A second allele of eppA in Borrelia burgdorferi strain B31 is located on the previously undetected circular plasmid cp9-2. J. Bacteriol. 182:6254-6258.
40. Norris SJ, Howell JK, Garza SA, Ferdows MS, Barbour AG. 1995. Highand low-infectivity phenotypes of clonal populations of in vitro-cultured Borrelia burgdorferi. Infect. Immun. 63:2206-2212.
41. Norris SJ, et al. 2011. High-throughput plasmid content analysis of Borrelia burgdorferi B31 by using Luminex multiplex technology. Appl. Environ. Microbiol. 77:1483-1492.
42. Ojaimi C, et al. 2003. Profiling of temperature-induced changes in Borrelia burgdorferi gene expression by using whole genome arrays. Infect. Immun. 71:1689-1705.
43. Ouyang Z, Blevins JS, Norgard MV. 2008. Transcriptional interplay among the regulators Rrp2, RpoN and RpoS in Borrelia burgdorferi. Microbiology 154:2641-2658.
44. Ouyang Z, et al. 2009. BosR (BB0647) governs virulence expression in Borrelia burgdorferi. Mol. Microbiol. 74:1331-1343.
45. Petney TN, Hassler D, Bruckner M, Maiwald M. 1996. Comparison of urinary bladder and ear biopsy samples for determining prevalence of Borrelia burgdorferi in rodents in central Europe. J. Clin. Microbiol. 34: 1310-1312.
46. Probert WS, Johnson BJ. 1998. Identification of a 47 kDa fibronectinbinding protein expressed by Borrelia burgdorferi isolate B31. Mol. Microbiol. 30:1003-1015.
47. Purser JE, et al. 2003. A plasmid-encoded nicotinamidase (PncA) is essential for infectivity of Borrelia burgdorferi in a mammalian host. Mol. Microbiol. 48:753-764.
48. Purser JE, Norris SJ. 2000. Correlation between plasmid content and infectivity in Borrelia burgdorferi. Proc. Natl. Acad. Sci. U. S. A. 97:13865-13870.
49. Rogers EA, et al. 2009. Rrp1, a cyclic-di-GMP-producing response regulator, is an important regulator of Borrelia burgdorferi core cellular functions. Mol. Microbiol. 71:1551-1573.
50. Sadziene A, Wilske B, Ferdows MS, Barbour AG. 1993. The cryptic ospC gene of Borrelia burgdorferi B31 is located on a circular plasmid. Infect. Immun. 61:2192-2195.
51. Samuels DS. 1995. Electrotransformation of the spirochete Borrelia burgdorferi. Methods Mol. Biol. 47:253-259.
52. Sarkar A, Hayes BM, Dulebohn DP, Rosa PA. 2011. Regulation of the virulence determinant OspC by bbd18 on linear plasmid lp17 of Borrelia burgdorferi. J. Bacteriol. 193:5365-5373.
53. Schwan TG, Burgdorfer W, Garon CF. 1988. Changes in infectivity and plasmid profile of the Lyme disease spirochete, Borrelia burgdorferi, as a result of in vitro cultivation. Infect. Immun. 56:1831-1836.
54. Schwan TG, Burgdorfer W, Schrumpf ME, Karstens RH. 1988. The urinary bladder, a consistent source of Borrelia burgdorferi in experimentally infected white-footed mice (Peromyscus leucopus). J. Clin. Microbiol. 26:893-895.
55. Steere AC, Coburn J, Glickstein L. 2004. The emergence of Lyme disease. J. Clin. Invest. 113:1093-1101.
56. Stevenson B, et al. 1997. Characterization of cp18, a naturally truncated member of the cp32 family of Borrelia burgdorferi plasmids. J. Bacteriol. 179:4285-4291.
57. Strother KO, de Silva A. 2005. Role of Borrelia burgdorferi linear plasmid 25 in infection of Ixodes scapularis ticks. J. Bacteriol. 187:5776-5781.
58. Tokarz R, Anderton JM, Katona LI, Benach JL. 2004. Combined effects of blood and temperature shift on Borrelia burgdorferi gene expression as determined by whole genome DNA array. Infect. Immun. 72:5419-5432.
59. Tourand Y, et al. 2006. Differential telomere processing by Borrelia telomere resolvases in vitro but not in vivo. J. Bacteriol. 188:7378-7386.
60. Tourand Y, Kobryn K, Chaconas G. 2003. Sequence-specific recognition but position-dependent cleavage of two distinct telomeres by the Borrelia burgdorferi telomere resolvase, ResT. Mol. Microbiol. 48:901-911.
61. Xu Q, McShan K, Liang FT. 2007. Identification of an ospC operator critical for immune evasion of Borrelia burgdorferi. Mol. Microbiol. 64: 220-231.
62. Xu Q, Seemanapalli SV, McShan K, Liang FT. 2006. Constitutive expression of outer surface protein C diminishes the ability of Borrelia burgdorferi to evade specific humoral immunity. Infect. Immun. 74:5177-5184.
63. Xu Y, Kodner C, Coleman L, Johnson RC. 1996. Correlation of plasmids with infectivity of Borrelia burgdorferi sensu stricto type strain B31. Infect. Immun. 64:3870-3876.